SCHEMBL22511693

SCHEMBL22511693

CCOC(=O)c1ccc2c(c1)c1c(n2CC)CCCC1

nearest known ligand 0.56

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ RORC P51449 3/20 0.56
▸ SCARB1 Q8WTV0 1/20 0.54
▸ NPC1 O15118 3/20 0.54
▸ RAB9A P51151 2/20 0.54
▸ MEN1 O00255 1/20 0.54
▸ KMT2A Q03164 1/20 0.54
▸ HSD17B10 Q99714 4/20 0.53
▸ KDM4E B2RXH2 5/20 0.51
▸ MAPT P10636 3/20 0.51
▸ ALOX15 P16050 3/20 0.51
▸ SMN1; SMN2 Q16637 1/20 0.51
▸ L3MBTL1 Q9Y468 1/20 0.51
▸ ALDH1A1 P00352 4/20 0.50
▸ HPGD P15428 1/20 0.50
▸ TSHR P16473 1/20 0.50
▸ PPARG P37231 1/20 0.49
▸ NCOA2 Q15596 1/20 0.49
▸ NCOA1 Q15788 1/20 0.49
▸ PTGER4 P35408 1/20 0.46
▸ GAA P10253 2/20 0.45

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6756508 0.89 SCARB1 (0.63) RORCSCARB1NPC1MEN1KMT2A
SCHEMBL4780961 0.87 SCARB1 (0.61) RORCSCARB1NPC1RAB9AMEN1
SCHEMBL6753135 0.85 KDM4E (0.67) RORCSCARB1NPC1RAB9AMEN1
SCHEMBL541347 0.83 AKR1B10 (0.61) RAB9AMEN1KMT2AHSD17B10KDM4E
SCHEMBL19271274 0.77 HSD17B10 (0.64) RORCRAB9AMEN1KMT2AHSD17B10
SCHEMBL5797538 0.77 MAPT (0.55) RORCSCARB1NPC1RAB9AMEN1
SCHEMBL4024319 0.76 SCARB1 (0.59) RORCSCARB1NPC1RAB9AMEN1
SCHEMBL4032588 0.76 SCARB1 (0.61) SCARB1NPC1MEN1KMT2AHSD17B10
SCHEMBL15865717 0.76 PTGER4 (0.65) SCARB1RAB9AMEN1KMT2AHSD17B10
SCHEMBL4030252 0.75 SCARB1 (0.70) RORCSCARB1NPC1HSD17B10KDM4E

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20230212143-A9 PRMT5 INHIBITOR COMPOUNDS UNIVERSITY OF FLORIDA RESEARCH FOUNDATION, INCORPORATED (US) 2023-07-06 — — US disclosed
US-20230212143-A9 PRMT5 INHIBITOR COMPOUNDS UNIVERSITY OF FLORIDA RESEARCH FOUNDATION, INCORPORATED (US) 2023-07-06 — — US disclosed
US-20220185792-A1 PRMT5 INHIBITOR COMPOUNDS UNIVERSITY OF FLORIDA RESEARCH FOUNDATION, INCORPORATED (US) 2022-06-16 — — US disclosed
WO-2020205660-A1 PRMT5 INHIBITOR COMPOUNDS UNIVERSITY OF FLORIDA RESEARCH FOUNDATION, INCORPORATED (US) 2020-10-08 — — WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20220185792-A1 PRMT5 INHIBITOR COMPOUNDS PRMT5, PRMT1, PRMT6 RORC 1947/4885SCARB1 4453/4885NPC1 2525/4885
US-20230212143-A9 PRMT5 INHIBITOR COMPOUNDS PRMT5, PRMT1, PRMT6 RORC 1947/4885SCARB1 4453/4885NPC1 2525/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback